Related Experiment Video
Updated: Jul 9, 2026
04:03
Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
A 24-year old man with persistent progressive breathlessness: early onset COPD.
Prem Parkash Gupta1, Dipti Agarwal
1Professor of Respiratory Medicine and Chief of the COPD Clinic, Postgraduate Institute of Medical Sciences, Rohtak, India. gparkas@yahoo.co.in
Summary
This case report details a 24-year-old male with early-onset emphysema, a severe lung disease, despite normal alpha-1-antitrypsin levels. The findings highlight the impact of early-onset smoking on respiratory health.
Area of Science:
- Pulmonology
- Radiology
- Genetics
Background:
- Chronic obstructive pulmonary disease (COPD) typically develops later in life.
- Early-onset emphysema is uncommon, particularly in individuals without genetic predispositions like alpha-1-antitrypsin deficiency.
Observation:
- A 24-year-old male with a history of heavy smoking since age 9 presented with an 8-year history of respiratory symptoms, initially treated for asthma.
- Spirometric studies and high-resolution computed tomography (HRCT) confirmed centrilobular emphysema, indicative of COPD.
- Blood alpha-1-antitrypsin levels were within the normal range.
Findings:
- The patient exhibited clinical and radiological evidence of COPD with centrilobular emphysema at a very young age.
- Normal alpha-1-antitrypsin levels ruled out genetic emphysema as the primary cause.
- This represents one of the youngest reported cases of emphysema in a smoker with normal alpha-1-antitrypsin.
Implications:
- This case underscores the severe impact of early-onset and prolonged smoking on lung health, leading to premature emphysema.
- It suggests that factors beyond alpha-1-antitrypsin deficiency contribute to early-onset emphysema in young smokers.
- Further research into genetic and environmental factors influencing early-onset COPD in smokers is warranted.
Related Concept Videos
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...